Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1174 of 5804
-
AI heart test could speed up lifesaving device implants
Diagnosis Recruiting nowThe goal of this clinical trial is to learn whether an artificial intelligence-enhanced electrocardiogram (AI-ECG) strategy improves timely intervention of patients requiring cardiac implantable electronic devices (CIEDs), compared with standard clinical care.
Phase: NA • Sponsor: National Defense Medical Center, Taiwan • Aim: Diagnosis
Last updated Jun 27, 2026 08:03 UTC
-
AI guides Doctors' lungs scope in pneumonia battle
Diagnosis Not yet recruitingThis study will evaluate an embodied-intelligence-assisted bronchoscopy navigation and diagnostic system for patients with severe pneumonia who require clinically indicated bronchoscopy. The system provides real-time visual cues and voice prompts to help physicians localize targe…
Phase: NA • Sponsor: Chinese Medical Association • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC
-
No knife needed? new procedure may treat appendicitis without surgery
Disease control Not yet recruitingThis study compares two ways of treating acute uncomplicated appendicitis, which is a mild form of appendicitis. In the Direct Visualization ERAT group, participants will receive Endoscopic Retrograde Appendicitis Therapy (ERAT). This is a minimally invasive, non-surgical treatme…
Phase: NA • Sponsor: Changhai Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New hope for elderly brain cancer patients: modified chemo schedule shows promise
Disease control Recruiting nowGlioblastoma is an aggressive type of brain cancer. Standard treatment usually includes three weeks of radiation therapy alone or combined with chemotherapy using Temozolomide. After a four- to six-week break, more Temozolomide chemotherapy is usually given. However, some tumors …
Phase: PHASE2 • Sponsor: Sunnybrook Health Sciences Centre • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
ER fluid showdown: which IV fluid saves more sepsis patients?
Disease control Not yet recruitingThis clinical trial aims to determine if the type of intravenous fluid used for initial resuscitation affects the short-term outcomes of adult patients with sepsis who are treated in the emergency department. The main questions it aims to answer are: Does using Ringer's lactate…
Phase: PHASE4 • Sponsor: Egemen Yildiz • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New hope for painful skin condition: experimental drug CIT-013 enters Mid-Stage trial
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if CIT-013 works to treat Hidradenitis Suppurativa in adults. It will also learn about the safety of CIT-013. The main questions it aims to answer are: Does CIT-013 lower the disease activity of HS patients? What medical problems do pa…
Phase: PHASE2 • Sponsor: Citryll BV • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Brain catcher: new device may prevent stroke during heart procedure
Disease control Recruiting nowThis is a prospective, multi-center, randomized controlled study. The goal of the study is to assess the safety and effectiveness of the Resonova® CHORDS® Cerebral Protection System in capturing and removing embolic debris during Transcatheter Aortic Valve Replacement (TAVR). A t…
Phase: NA • Sponsor: Resonova (Shanghai) Medtech Limited • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New injectable drug hopes to boost heart function in PAH patients
Disease control Not yet recruitingPulmonary Arterial Hypertension (PAH) is a serious condition that puts strain on the right side of the heart. While oral medications can help, many patients with intermediate-risk PAH may not see enough improvement, and their heart function can continue to decline. This study ai…
Phase: PHASE2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 26, 2026 18:35 UTC
-
Can a pill prevent dangerous platelet drops during breast cancer treatment?
Disease control Not yet recruitingAdo-trastuzumab emtansine (T-DM1) demonstrates favorable efficacy in breast cancer treatment but is frequently associated with thrombocytopenia. Multiple studies indicate that Asian populations face a higher risk of developing thrombocytopenia during T-DM1 therapy, with incidence…
Phase: NA • Sponsor: Zhenzhen Liu • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Can an 8-Week online course stop depression before it starts?
Prevention Recruiting nowThe present study aims to pilot internet-delivered Skills Training in Affective and Interpersonal Regulation (i-STAIR) as a transdiagnostic emotion dysregulation intervention to prevent progression to depression in individuals with adverse childhood experiences (ACEs) and subsynd…
Phase: NA • Sponsor: Institute of Mental Health, Singapore • Aim: Prevention
Last updated Jun 27, 2026 09:09 UTC
-
New stroke drug HRS-7450 enters Mid-Stage trial
Disease control OngoingThis study plans to enroll a total of 208 patients with Acute Ischemic Stroke (AIS) who present within 4.5 to 24 hours of symptom onset and meet the specified imaging criteria.
Phase: PHASE2 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Fiber fuel: could a High-Fiber diet boost cancer treatment?
Disease control Recruiting nowCancer remains a major global public-health challenge and a central focus of medical research. According to the International Agency for Research on Cancer (IARC, 2020), 19.29 million new malignant tumors and 9.96 million cancer deaths occurred worldwide, \>90 % being solid cance…
Phase: PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Could a Once-a-Year cholera shot be just as good?
⭐️ VACCINE ⭐️ Recruiting nowBackground: Despite efforts to control cholera, outbreaks continue to occur in Kenya. Oral cholera vaccines (OCVs) are a critical tool in cholera prevention strategies. This study evaluates the immunogenicity of extended dosing intervals for Euvichol-S, a WHO-prequalified OCV, in…
Phase: PHASE4 • Sponsor: Albert B. Sabin Vaccine Institute • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:00 UTC
-
AI reads your face to keep brain training on track
Disease control Recruiting nowHow to ensure adherence to computerized cognitive training in unsupervised circumstances (e.g., at-home, self-administered) in older adults at risk for Alzheimer's disease (AD) or AD related dementia (AD/ADRD) is understudied. The objective of the R33 study is to test a novel fac…
Phase: PHASE1, PHASE2 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a phone app improve depression care?
Symptom relief Recruiting nowMood disorders like depression and bipolar disorder are widespread and cause serious psychological, cognitive, and social impairments, with a high burden on healthcare systems. Edra PRO is a digital medical device developed to support clinical decision-making and remotely monitor…
Phase: NA • Sponsor: Resilience • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
New cocktail aims to stop Chemo-Induced sickness in stem cell transplants
Symptom relief Recruiting nowThis study employs a prospective, multicenter, randomized, two-arm design aimed at evaluating the efficacy and safety of the FTO regimen in preventing delayed chemotherapy-induced nausea and vomiting (CINV) following high-dose chemotherapy for hematopoietic stem cell transplantat…
Phase: PHASE3 • Sponsor: The Affiliated People's Hospital of Ningbo University • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
New drug combo aims to keep advanced lung cancer in check
Disease control Recruiting nowThis is an open-label, single-arm, phase 2 study to evaluate the safety and efficacy of golidocitinib with PD-1 inhibitors as maintenance treatment in patients with previously untreated extensive-stage small cell lung cancer.
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New pill could boost breathing in pompe disease – early trial underway
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, pharmacodynamics (PD), and exploratory clinical efficacy of S-606001 in adult participants with LOPD as an add-on to ERT.
Phase: PHASE2 • Sponsor: Shionogi • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Virtual coach on your phone aims to boost opioid recovery
Disease control Recruiting nowThis study aims to improve retention in buprenorphine treatment, a medication used for opioid use disorder, through the use of a smartphone-delivered recovery support intervention. The intervention involves an Embodied Conversational Agent (ECA), a virtual, animated computer agen…
Phase: NA • Sponsor: Boston Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New pill could soothe stubborn hives when allergy meds fail
Symptom relief Recruiting nowThe purpose of the study is to learn about the safety and effects of the study medicine (called ritlecitinib) for the treatment of chronic spontaneous urticaria (CSU) that is not effectively treated by antihistamines which are used to stop the body's "allergy alarm system" from o…
Phase: PHASE2 • Sponsor: Pfizer • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC